Stéphane Durant des Aulnois, MSc 

Stéphane Durant des Aulnois is the CBO of Ona Therapeutics. He is responsible for guiding partnerships and financing strategies. He has extensive experience in investor relations and private equity and concurrently maintains the role of CFO at Corteria Pharmaceuticals. Previously, Stéphane served as CFO and Head of Alliances and Business Development at Lysogene, a Phase 3 gene therapy company listed on Euronext, and spent nine years at Ipsen, first as Vice-President Head of Investor Relations for the Group, then as CFO of Ipsen Iberia. Earlier in his career, he worked in Private Equity at LaSalle Investment management, at Calyon Americas and at Exane BNP Paribas as a sell-side research Analyst. He holds a MSc in Accounting and Finance from the London School of Economics (LSE) and in Management from Paris Dauphine University. He also holds an Executive Leadership degree from Harvard Business School.